tirzepatide and metabolism Shifting the Scales: Tirzepatide's Breakthrough in Obesity Management Tirzepatide for Medical Weight Loss
Description
Blockade of the GLP-1 receptor and subdiaphragmatic vagal transmission rescued the deficient locomotor phenotype in ABX-treated mice
All you want is to feel better, but you feel frustrated and unheard because what you have been doing isnt working
What it is
Patients who reduced the frequency of GLP-1 dosing (from weekly to every other week) were able to maintain their weight loss and metabolic syndrome gains, as reported in this case series
These results provide new insights into the molecular basis of ligand specificity in class B GPCRs and may facilitate the development of more specific therapeutics.
